Companies / Rapport Therapeutics, Inc. / Activity
Activity — Rapport Therapeutics, Inc.
4 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2024 as of | Barclays PLC 13F manager | New | Common Stock | $218.6K | +9K | 9,400 0.02% of shares | low |
| Q1 2026 as of | Zurcher Kantonalbank (Zurich Cantonalbank) 13F manager | New | Common Stock | $16.1K | +513 | 513 <0.01% of shares | low |
| Q1 2026 as of | MAI Capital Management 13F manager | New | Common Stock | $188 | +6 | 6 <0.01% of shares | low |
| Q2 2026 as of | Covestor Ltd 13F manager | New | Common Stock | $1 | +17 | 17 <0.01% of shares | low |